Status:
COMPLETED
Impacts of a Combined Berry Extract Supplement on Vascular Function and Oxygen Utility Capacity in Young Adults
Lead Sponsor:
University of Nebraska
Conditions:
Healthy
Eligibility:
All Genders
19-35 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the impacts of a combined berry extract supplement (hawthorn berry, tart cherry, and bromelain extracts) on total antioxidant capacity, endothelial function...
Detailed Description
There are several proposed mechanisms that are thought to contribute to the development of cardiovascular diseases. Although the process is extremely complex, it is well-accepted that elevated levels ...
Eligibility Criteria
Inclusion
- otherwise healthy adult
Exclusion
- cardiovascular disease
- neurological disorder
- metabolic disorder
- respiratory disorder
- renal diseases
- musculoskeletal injury
- bleeding disorder
- allergy to fruit
- pregnant/breast feeding
- taking daily medication (prescription or over-the-counter)
Key Trial Info
Start Date :
November 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 13 2019
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04312022
Start Date
November 4 2018
End Date
June 13 2019
Last Update
February 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Nebraska at Omaha
Omaha, Nebraska, United States, 68182